Total Payments
$1.2M
2024 Payments
$50,093
Companies
23
Transactions
1,545
Medicare Patients
2,366
Medicare Billing
$173,759
Payment Breakdown by Category
Other$858,950 (74.0%)
Travel$183,421 (15.8%)
Consulting$84,094 (7.2%)
Food & Beverage$34,239 (2.9%)
Education$27.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $789,215 | 352 | 68.0% |
| Travel and Lodging | $183,421 | 583 | 15.8% |
| Consulting Fee | $84,094 | 48 | 7.2% |
| Honoraria | $63,985 | 34 | 5.5% |
| Food and Beverage | $34,239 | 522 | 2.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,750 | 4 | 0.5% |
| Education | $27.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $608,329 | 853 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $362,859 | 436 | $0 (2024) |
| Edwards Lifesciences Corporation | $63,558 | 93 | $0 (2018) |
| Fisher Scientific Company L.L.C. | $51,382 | 66 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $19,224 | 31 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $14,700 | 11 | $0 (2023) |
| Vifor Pharma, Inc. | $10,400 | 3 | $0 (2023) |
| Fisher & Paykel Healthcare Limited | $9,409 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $5,750 | 4 | $0 (2024) |
| PFIZER INC. | $4,499 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,093 | 90 | Janssen Pharmaceuticals, Inc ($31,919) |
| 2023 | $162,497 | 179 | AstraZeneca Pharmaceuticals LP ($84,318) |
| 2022 | $177,502 | 217 | AstraZeneca Pharmaceuticals LP ($83,940) |
| 2021 | $193,047 | 280 | AstraZeneca Pharmaceuticals LP ($148,129) |
| 2020 | $176,012 | 246 | AstraZeneca Pharmaceuticals LP ($153,323) |
| 2019 | $174,109 | 247 | AstraZeneca Pharmaceuticals LP ($125,135) |
| 2018 | $93,479 | 123 | Janssen Pharmaceuticals, Inc ($58,858) |
| 2017 | $133,992 | 163 | Janssen Pharmaceuticals, Inc ($100,799) |
All Payment Transactions
1,545 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $51.74 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $500.00 | General |
| 11/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $181.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $40.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $35.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 10/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $210.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $85.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Rare Disease | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $111.19 | General |
| Category: Rare Disease | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Rare Disease | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $39.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $12.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $483.41 | General |
| Category: Rare Disease | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $225.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $198.63 | General |
| Category: Rare Disease | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $178.27 | General |
| Category: Rare Disease | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $111.60 | General |
| Category: Rare Disease | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 319 | 341 | $379,170 | $32,118 |
| 2022 | 5 | 392 | 401 | $322,483 | $33,249 |
| 2021 | 7 | 751 | 802 | $178,129 | $49,363 |
| 2020 | 8 | 904 | 964 | $219,030 | $59,030 |
Total Patients
2,366
Total Services
2,508
Medicare Billing
$173,759
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 124 | 127 | $203,492 | $17,791 | 8.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 44 | 48 | $99,199 | $8,204 | 8.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 63 | 63 | $68,395 | $5,473 | 8.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 88 | 103 | $8,083 | $649.78 | 8.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 140 | 144 | $198,862 | $21,496 | 10.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 61 | 61 | $57,636 | $5,768 | 10.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 23 | $46,120 | $4,117 | 8.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 150 | 155 | $9,918 | $950.89 | 9.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 18 | 18 | $9,946 | $916.60 | 9.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 140 | 143 | $77,156 | $22,522 | 29.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 61 | 62 | $34,286 | $8,701 | 25.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 31 | $20,274 | $5,883 | 29.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 47 | 47 | $17,390 | $4,662 | 26.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 51 | 51 | $11,067 | $2,892 | 26.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 398 | 445 | $11,125 | $2,857 | 25.7% |
| 99218 | Hospital observation care, typically 30 minutes | Facility | 2021 | 23 | 23 | $6,831 | $1,845 | 27.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 165 | 172 | $90,122 | $24,673 | 27.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 89 | 90 | $49,770 | $13,400 | 26.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 36 | 36 | $23,940 | $6,683 | 27.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 84 | 85 | $18,445 | $4,803 | 26.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 472 | 523 | $13,075 | $3,530 | 27.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 31 | 31 | $11,154 | $2,809 | 25.2% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2020 | 16 | 16 | $10,368 | $2,656 | 25.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 11 | 11 | $2,156 | $475.97 | 22.1% |
About Dr. James Neuenschwander, MD
Dr. James Neuenschwander, MD is a Emergency Medicine healthcare provider based in Mount Vernon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740210749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Neuenschwander, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $50,093 received in 2024. These payments were reported across 1,545 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($789,215).
As a Medicare-enrolled provider, Neuenschwander has provided services to 2,366 Medicare beneficiaries, totaling 2,508 services with total Medicare billing of $173,759. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Mount Vernon, OH
- Active Since 07/04/2006
- Last Updated 10/30/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1740210749
Products in Payments
- LOKELMA (Drug) $495,401
- XARELTO (Drug) $363,008
- ANDEXXA (Biological) $113,676
- Procalcitonin (Device) $23,468
- BRAHMS PCT KRYPTOR (Device) $20,456
- Andexxa (Drug) $15,648
- FISHER & PAYKEL HEALTHCARE (Device) $9,409
- Procalcitonin (Drug) $7,458
- CD cobas Reagents (Device) $2,520
- ALINITY (Device) $1,200
- ClearSight System (Device) $1,001
- OTHER- BSC PRODUCT NOT LISTED (Device) $750.00
- LATITUDE (Device) $500.00
- MD cobas Instruments and Reagents (Device) $368.40
- Fluid Systems - Research Devel (Biological) $310.00
- Architect i2000SR Analyser System (Device) $159.78
- EV1000 Clinical Platform (Device) $139.88
- RELISTOR (Drug) $127.17
- Puraply Antimicrobial (Medical Supply) $120.66
- Reagent (Device) $107.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Mount Vernon
Dr. Bhuvanaprasad Mandalapu, Md, MD
Emergency Medicine — Payments: $2,887
Emergency Medicine $2,887
Dr. Rebecca Link, Md, MD
Emergency Medicine — Payments: $1,299
Emergency Medicine $1,299
Dr. Zareen Khan, Md, MD
Emergency Medicine — Payments: $1,193
Emergency Medicine $1,193
Lisa Parker, Md, MD
Emergency Medicine — Payments: $899.60
Emergency Medicine $899.60
Edgardo Emilia, Md, MD
Emergency Medicine — Payments: $843.96
Emergency Medicine $843.96
Christie Foster, M.d, M.D
Emergency Medicine — Payments: $840.67
Emergency Medicine $840.67